Compare Abbott Laboratories (ABT) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs VanEck Junior Gold Miners — how do they compare? Abbott Laboratories trades at $95.55 (market cap $166.94B), while VanEck Junior Gold Miners trades at $95.32. The key difference: Abbott Laboratories pays a 2.63% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals.
| ABT | GDXJ | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $136.62 | $156.19 |
52-Week Low | $82.57 | $64.22 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
GDXJ trades at $103.91, up 0.97% today, with technical indicators showing mixed signals (neutral overall, bearish moving averages). The ETF faces headwinds from underperformance versus peers in 2026, with significant portfolio overlap and limited small-cap exposure. Recent news highlights silver price volatility and gold's rally near $4,700, affecting junior miner sentiment.
The outlook remains cautious due to Federal Reserve rate uncertainty and competitive pressures. Investment opportunities hinge on gold price sustainability, but risks include sector underperformance and macroeconomic sensitivity. Analyst sentiment is neutral to bearish, reflecting concerns over the ETF's strategic positioning and recent returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
